CCN2 and malignant mesothelioma: Furthermore, defects of the Hippo pathway in malignant mesothelioma, synergize with TGF-β signaling to induce the common target CTGF (connective tissue growth factor) which results in matrix deposition, similarly, to what is observed in the fibrotic disease (Wang et al., 2016b).